|
MRPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.26969999994608E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.920000E-01 |
| Stage1-vs-Stage3 |
5.22739999953004E-07 |
| Stage1-vs-Stage4 |
1.602880E-04 |
| Stage2-vs-Stage3 |
1.196200E-03 |
| Stage2-vs-Stage4 |
6.115100E-03 |
| Stage3-vs-Stage4 |
3.273400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.62569957495862E-12 |
| Normal-vs-Asian |
4.33569999902517E-08 |
| Caucasian-vs-AfricanAmerican |
7.622800E-01 |
| Caucasian-vs-Asian |
1.027570E-01 |
| AfricanAmerican-vs-Asian |
1.094030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.161400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.61755070343861E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
6.99180002783351E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.906400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.530200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.291400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.799600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.109200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.939200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.83649999999847E-05 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
5.854800E-01 |
| Grade 1-vs-Grade 3 |
6.896200E-02 |
| Grade 1-vs-Grade 4 |
1.875900E-03 |
| Grade 2-vs-Grade 3 |
3.001000E-04 |
| Grade 2-vs-Grade 4 |
8.44180000347805E-08 |
| Grade 3-vs-Grade 4 |
1.106300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
1.81359999995578E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.8018997405278E-10 |
| N0-vs-N1 |
2.316600E-01 |
|
|
